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In spite of the clinical importance of allergic disturbances pro-
duced by quinines, salicylates, and barbiturates, very few experi-
ments on sensitization to these drugs are published. Landsteiner
(1) wrote in 1936 ". . . there remains the fact that with many
simple compounds (quinine, aspirin, antipyrine, iodoform, et
cetera) to which certain individuals are highly sensitive artificial
sensitization has not yet been effected in man or animals."
The following is a brief review of several of the more recent
attempts to induce experimental cutaneous sensitizations of
guinea pigs to some of the drugs mentioned in the above quotation
from LancLsteiner.
Landsteiner and Jacobs (2) failed to obtain skin sensitization in guinea pigs
with quinine and acetyl salicylic acid by their methods (repeated intracutaneous
injections, etc.). Morishita did not succeed in producing typical anaphylactic
symptoms in guinea pigs or rabbits by quinine. M. Silverberg (4) elicited epi-
dermal hypersensitivity to "mesotan," a salicylic acid compound in man by
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The first article in this series is "Further Studies in Arsphenamine Hypersensi-
tiveness in Guinea Pigs. I. Cutaneous and Anaphylactic Responses td Old
Arsphenamine and to Neoarsphenamine after Sensitization with Old Arsphen-
amine" by Wilhelm Frei and Marion B. Sulzberger. Jour. Invest. Dermat.,
1:191, June, 1938.
111
112 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
external applications, whereas her animal experiments with this substance were
negative.
In 1939, M. Suzuki (5) reported positive results in sensitizations of guinea pigs
with acetyl salicylic acid: animals treated by intracutaneous, intravenous, or
intraperitoneal injections, or by oral administration, showed marked skin hyper-
sensitivity to this substance and gave erythematous local reactions when the drug
was reinjected intracutaneously two weeks after sensitization. Moreover, cuta-
neous hypersensitivity could be established passively by the intravenous injection
of the serum of the sensitized guinea pigs into untreated animals. Guinea pigs
sensitized by any of these routes exhibited mild anaphylactic symptoms after
intravenous reinjection or oral administration of acetyl salicylic acid and gave
slightly positive results when examined by the Schultz-Dale technique.
The following report deals with attempts at experimental
specific cutaneous sensitization of guinea pigs to quinine hydro-
chloride, acetyl salicylic acid, and barbital. Since in former
experiments of Landsteiner and Jacobs (2) with two of these drugs
(quinine and acetyl salicylic acid) the customary methods of sensi-
tization had failed to give results, in these attempts some special
methods were employed. Two of the experiments made use of the
sensitization of the guinea pigs' skin to arsphenamine (Frei (6),
Sulzberger (7), Landsteiner and Jacobs (8), Frei and Sulzberger
(9) et al.) in the attempt to increase the susceptibility to sensitiza-
tion to the other drugs.
The results were uniformly negative. Even in the case of acetyl
salicylic acid it was not possible to achieve sensitization. This
finding agrees with the results of Landsteiner and Jacobs—and is
in contrast to the report of M. Suzuki, who, as above mentioned,
stated that he had been able to elicit skin sensitization by means
of this drug administered by widely different routes.
In spite of the negative results of the present experiments, it
appeared to the author that the significance of the questions which
were involved, as well as some additional observations, justify the
following short report.
EXPERIMENT I
It has been learned empirically, for instance, from experience
acquired in modern anti-syphilitic therapy, that individuals with
allergic hypersensitivity to one drug, when changing to another,
are inclined to exhibit allergy to the second or third drug more
frequently than does the average, not previously sensitized pa-
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tient. In some of these cases the allergic disturbances due to
the second drug appear shortly after its first administration; in
others they appear after a longer lapse of time and perhaps only
after several administrations. Thus the impression arises that
two groups of "multivalent" drug hypersensitivity might exist,
one produced by sensitization to a single drug, and the other by a
sequence of sensitizations to different preparations.
Similar clinical observations have been made with regard to external allergens
in contact-type eczematous dermatitis, and extensive experimental investigations
in man have supplied further information here (see Sulzberger (10)). By means of
J. Jadassohn's patch-test method, Br. Bloch (11), Jaeger (12), Tachau (13) and
other authors have demonstrated that patients with allergic eczematous contact-
type dermatitis are more likely than others to be sensitive to several different
eczematogenous allergens. Wedroff and Dolgoff (14) and Sulzberger and Rosten-
berg, Jr. (15) proved experimentally that such patients are also more susceptible
to experimental sensitization with additional allergens of this type.
In drug hypersensitivity corresponding experimental studies
of combined sensitizations are almost entirely lacking.'
The following preliminary experiment deals with the question
as to whether previous sensitization to arsphenamine might bring
about or augment a later sensitization of the guinea pig's skin to
other non-related drugs.
A series of guinea pigs which had acquired a strong allergic
hypersensitivity to arsphenamine (old arsphenamine) by intracu-
taneous injections (6, 7, 8, 9) were treated several months later
by frequent intracutaneous injections of either quinine hydro-
chloride, or acetyl salicylic acid, or barbital. When the particular
drug in question was reinjected two and four weeks afterwards,
no sign of acquired allergic hypersensitivity could be found, while
the cutaneous arsphenamine allergy still persisted (see protocol 1).
These negative results correspond to earlier unpublished experi-
ments of Sulzberger with neoarsphenamine plus gold salts,2 and of
Frei with arsphenamine plus sulfanilamide.
1 Some experiments on "chemical analysis" of hypersensitivity to arsphen-
amine, quinine, or other drugs (Frei and R. Mayer (16), Sulzberger and F. A.
Simon (17), Dawson and co-workers (18), et al.) do not belong exactly in this
field, because the choice of the test substances was limited to preparations re-
lated to the original allergen.
2 Personal communication to the author.
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Protocol 1
On December 13th, 1939, 9 white virgin guinea pigs, each weighing approxi-
inately 250—300 grams were injected intracutaneously with 0.1 cc. of a solution of
0.1 arsphenamine Hoechst in 100 cc. distilled water. Most of the animals showed
spontaneous flare-ups after 6—7 days (6, 7, 8, 9). All of them were proved sensi-
tized to arephenamine when reinjected with a solution of the original strength
after four weeks.
Four and one-half months after the first injection of arsphenamine the attempt
was made to sensitize the skin of the same 9 animals—now weighing 500—700
grams—to one of the above-mentioned drugs. Each animal received intracuta-
neous injections of the aqueous solutions twice daily for six consecutive days.
The solutions were prepared freshly every day. Three animals received 0.1 c.cm.
ofa solution of 0.2 per cent of qwinine hydrochloride N.F.; three other animals
0.1 c.cm. of a half-saturated solution of acetyl salicylic acid U.S.P. (about 1:600);
and the three remaining animals 0.1 c.cm. of a half-saturated solution of barbital
U.S.P. (about 1:260). The immediate reactions following the injections of each
of these drugs consisted of wheals of about 4—8 mm. in diameter; the late reactions
consisted of slightly elevated, slightly inflammatory papules of about 4—6 mm.,
in some cases topped by a small crust.
In the case of quinine, about 9—10 days after the injections were begun, the
papules resulting from the earlier injections became somewhat more elevated
and harder without showing any considerable increase of inflammation; some days
later the papules resulting from the last injections showed similar changes. When
quinine solution of the same strength as that used in the beginning was reinjected
intracutaneously two weeks after the start of the first series, the papules of the
first series showed a mild focal reaction. The local reaction to these reinjections
did not differ in any way from those following the first injections; tiere was also
a slight increase in consistency and height of these papules after about 8 days.
A second intracutaneous injection after an interval of two more weeks (observed
for only 48 hours) gave the same immediate and late reactions as did the first
series. No focal reactions were observed at the sites of the previous injections.
A repetition of the series of quinine injections in three other animals sensitized
to arsphenamine and in three nonsensitized animals produced the same phe-
nomenon of increase in height and consistency after about 9 days; no difference
between the arsphenamine sensitive and the non-sensitive group was observed.
In order to examine whether the focal reactions as described above were of
specific character, 10 other guinea pigs previously sensitized to arsphenamine were
treated with a series of intracutaneous injections of quinine. Thirteen days after
the beginning of this treatment, when the nodule formation was at its height, four
of the animals received 0.2 cc. of 0.2 per cent quinine hydrochloride solution,
three 0.2 cc. of 1 per cent aminopyrine solution, and three 0.2 cc. of an arsphen-
amine solution 0.1:4000. However, this time focal reactions at the site of the
first quinine injections were not observed in any of the three groups after 24 hours.
After 48 hours the results were doubtful in the quinine and in the arsphenamine
group and negative in the aminopyrine group.
In the case of acetyl salicylic acid, the same phenomenon of increase in con-
sistency of the papules after 9—10 days was observed, but to a lesser degree. Focal
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reactions following reinjection after two weeks were not seen. R.eineotions after
two and four weeks gave no signs of sensitization.
In the case of barbital, no nodule formation—as described above in the case
of quinine and acetyl salicylic acid—was seen. No sensitization was obtained
after two and four weeks.
When at the end of this experiment, 5 months after the first sensitizing in-
jection of arsphenamine and 41 months after the first reinjection of this prepara-
tion, a second intracutaneous reinjection of arsphenamine was made (0.1 cc.
of a solution of 0.15:100 arsphenamine Winthrop) the skin of the guinea pigs
reacted to arsphenamine as strongly as a series of freshly sensitized control
animals reinjected at the same time.
EXPERIMENT 2
Landsteiner (1) et a!., in fundamental experiments on haptens
demonstrated that certain simple chemicals acquire sensitizing
properties by preliminary conjugation with proteins. Br. Bloch
and Steiner-Wourlisch (19), Frei (6), Sulzberger (7), Landsteiner
and Jacobs (2) et aL showed later that certain other simple chem—
icals probably do not require such preliminary conjugation but
seem to be capable of producing hypersensitivity by themselves.
This raises the question whether chemicals of the latter kind,
such as arsphenamine, may not—in addition to being in themselves
full sensitizing agents or full allergens—also complete the action
of other chemicals to which they are added.
In the experiments of Landsteiner and van der Scheer (20), guinea pigs sensi-
tized to certain azoproteins also died in anaphylactic shock when reinjected with
preparations which contained the same azo-compound and in which the protein
was replaced by resorcinol. In recent experiments of Hedén (21) Forssman anti-
bodies were produced in man by injecting Forssxnan hapten mixed with neoars-
phenamine or other chemotherapeutic agents of the benzene group. Hedén
interpreted his results as indicating that these chemotherapeutic agents acted
like hog serum or other proteins in completing the antigenic property of the
hapten.
M. Suzuki (5) reported that in his experiments on sensitization of guinea pigs
to acetyl salicylic acid addition of potassium alum or of horse serum intensified
noticeably the sensitizing ability of the acetyl salicylic acid. In experiments of
Haxthausen (22) in man, simple admixture with horse serum did not suffice to
raise the sensitizing power of neoarsphenamine. Only chemicals forming con-
jugates with horse serum, as mercury bichloride, formaldehyde, or chromic acid,
acquired sensitizing properties by admixture.
In analogy of the procedure of Hedén with regard to Forssman
hapten, some preliminary experiments were done in which simple
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mixtures of arsphenamine (old arsphenamine) and of quinine
hydrochloride, acetyl salicylic acid, or barbital respectively were
injected intracutaneously into a series of guinea pigs on three
consecutive days. Four weeks later these animals were tested
intracutaneoilsly, first with quinine, acetyl salicylic acid, or
barbital alone, and then with mixtures of each drug and of
arsphenamine and at the same time with arsphenamine alone.
The skins of the animals did not show any sign of sensitization to
quinine, acetyl salicylic acid, or barbital alone. They gave the
customary allergic reactions to arsphenamine alone. To mixtures
of arsphenamine and the other drugs they reacted in exactly the
same manner and with the same intensity as they did to arsphen-
amine alone (see protocol 2, of Experiment 2).
Protocol
Nine white virgin guinea pigs of the same breed as those used in experiment I,
and weighing 500—700 grams, received, on three consecutive days, intracutaneous
injections of 0.1 cc. of one of three aqueous solutions used 5 minutes after prepara-
tion: three animals received a solution of 0.2 per cent quinine hydrochloride N.F.
and 0.15 per cent arsphenamine Winthrop; three animals received a half saturated
solution of acetyl salicylic acid U.S.P. (about 1:600) together with 0.15 per cent
arephenamine; and three animals recejved a half-saturated solution of barbital
U.S.P. (about 1:260) also containing 0.15 per cent arsphenamine.
All of the animals gave mild late reactions to the injections. Most of them,
after 9—10 days, showed flare-ups of the same papular type as are usually seen after
arsphenamine injections.
Four weeks after the first injection the animals received an intracutaneous
injection of 0.1 cc. of the appropriate drug, i.e., either quinine hydrochloride
(0.2 per cent) or acetyl salicylic acid (half saturated) or barbital (half saturated).
There was no evidence of sensitization, and the guinea pigs of this experiment
gave immediate and late reactions of the same kind and intensity as the animals
of experiment I and III reinjected at the same time.
Three days later all of the animals of this series received intracutaneous in-
jections of 0.1 cc. of 1) arsphenamine solution 0.15:100, 2) the same arsphenamine
solution containing at the same time 0.2 per cent quinine hydrochloride, 3) the
same arsphenamine solution containing acetyl salicylic acid in half saturation,
and 4), the same arsphenamine solution containing barbital in half saturation.
All of these animals gave allergic reactions to all of the injections. The re-
actions to the mixtures did not differ in any way from those to pure arsphenamine
alone.
EXPERIMENT 3
In a third series of guinea pigs, frequently repeated intracuta-
neous injections of quinine hydrochloride, acetyl salicylic acid,
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or barbital respectively were made into one and the same area.
The same procedure was used by Lehner and Rajka (23) in at-
tempts to sensitize human skin to trichophytin, tuberculin, und
luetin. It represents a modification of a method introduced by
J. Jadassohu (24) for epidermal sensitization.
In the experiment here reported repeated injections into the
same area also did not elicit any positive result (see protocol 3).
Protocol 3
Nine white virgin guinea pigs of the same breed as those used in experiment
I and II, and weighing 500—700 grams, received twice daily, on six consecutive
days, an intracutaneous injection of 0.1 cc. of one of three aqueous solutions:
Three received a solution of 0.2 per cent quinine hydrochloride, three a half
saturated solution of acetyl salicylic acid, and three animals received a half
saturated solution of barbital. The solutions were freshly prepared every day.
The injections were made into the same area, first into the centre and later, after
infiltration and ulceration had appeared in the central parts, into the periphery
oJ the nodules. There was formation of an ulceration and subsequently of a
deep scar at all sites.
Four weeks after the beginning of the injections the animals received, on an
intact part of the skin (flank), an intracutaneous reinjection of 0.1 cc. of the same
solution with which they were treated previously. There was no sign of sensi-
tization, and the guinea pigs gave iimnediate and late reactions of the same kind
and intensity as they had at the beginning of the experiment, and as did the
animals of experiment I and II reinjected at the same time.
In the course of the experiments just reported some additional
observations were made which may be summarized as follows:
a) Guinea pigs first injected with arsphenamine 5 months
previously and last tested with the same drug- 4 months previ-
ously were as sensitive to reinjections of arsphenamine as newly
sensitized animals (see Kaplun and Moreinis (25), Cormia (26)).
b) Full grown guinea pigs of 500—700 grams could be sensitized
to arsphenamine (old arsphenamine) with the same ease as
younger animals of 250—300 grams (see M. B. Cohen (27)). This
supplements former experiments of the present author (28) who
found that the ability of guinea pigs to become sensitized to
arsphenamine (neoarsphenamine) begins at the age of three weeks
and is fully developed at the age of five weeks.
c) The addition of quinine in a concentration of 0.2 per cent,
of acetyl salicylic acid in half saturation, or of barbital in half
saturation did not influence in any way the sensitizing power of an
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aqueous 0.15 per cent arsphenamine solution or the ability of this
solution to elicit skin reactions in previously sensitized guinea
pigs. This fact was especially noteworthy in the case of the
quinine, arsphenamine mixture; for, the addition of the quinine
produced visible changes in the arsphenamine solution. It
became opaque and intensively fluorescent after a few minutes.
Upon increasing the amount of quinine a precipitate was formed.
The pH of the 0.15 per cent arsphenamine solution was diminished
by addition of 0.2 per cent quinine from 2.6 to 3.6. The surface
tension of the solution was not changed by the addition. Despite
these apparent changes, the sensitizing capacity of the arsphen-
amine and its ability to elicit skin reactions in previously sensi-
tized guinea pigs were apparently unaltered.
d) The same guinea pigs showed no differences in the intensity
of allergic skin reactions to arsphenamine whether one injected
full or half strength solutions, whether the injected amount was
0.1 cc. or a little more or less, whether the injection was made very
superficially or a little more deeply. However, among the individ-
ual animals there were strong differences in the reactivity even to
one and the same solution applied exactly in the same way and
in the same quantity.
e) In guinea pigs treated with quinine hydrochloride, hard,
slightly inflammatory nodules of about the size of a rice grain de-
veloped at the sites of the deposits some days after a series of intra-
cutaneous injections. Similar nodules were also observed after
injections of other chemicals e.g. of acetyl salicylic acid (see also
Landsteiner and Jacobs (2)). In the case of quinine, the nodules
were especially large so that the suspicion of a small "flare-up"
arose, which, if true, would have meant the beginning of a sensi-
tization. The suspicion was strengthened by a mild focal reaction
appearing at the sites of the nodules of first injection after an
intracutaneous reinjection of quinine at a remote site. However,
the animals proved to be non-sensitized. This was indicated
by several findings, among them the observation that the local
reactions to intracutaneous reinjections to quinine in new skin
areas did not differ in any way from those to the first injections.
This phenomenon of focal reaction turned out to be inconstant.
In order to see whether it was of specific character, another series
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of guinea pigs was prepared by quinine in the same way. No
definite focal reactions to quinine or other substances were ob-
served this time at the sites of the nodules after reinjections (see
protocol 1).
The nodules apparently represent the product of a non-specific
inflammation and correspond to inflammatory nodules which may
develop in man after subcutaneous injections of certain drugs,
e.g., phenobarbital sodium or codeine and without sensitization
to these drugs. Also in man mild focal reactions are sometimes
observed after reinjections of those agents or even after oral intake
without there being any sign of allergic sensitivity to the particular
drug.3
SUMMARY
In the attempt to achieve cutaneous sensitization of guinea pigs
to quinine hydrochloride, to acetyl salicylic acid, or to barbital,
three different methods were used: 1) repeated intracutaneous
injections into animals whose skins had first been specifically
sensitized to old arsphenamine. 2) repeated intracutaneous
injections of in vitro mixtures of each of these drugs and of old
arsphenamine. 3) repeated intracutaneous injections into the
same area.
None of these methods gave positive results, and no synergistic
or potentiating action was found.
Some additional observations made in the course of these
experiments are reported.
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